Bayer Launches Thromboembolic Pulmonary Hypertension Drug Adempas In Japan
This article was originally published in PharmAsia News
Executive Summary
Bayer has launched Adempas tablets (riociguat) for the treatment of inoperable or recurrent chronic thromboembolic pulmonary hypertension in Japan.